Evidence map›Paper›PMID 35324685›Full record

ReviewToxins2022

The Potential of Fatty Acids and Their Derivatives as Antifungal Agents: A Review.

Ana Guimarães, Armando Venâncio

Open access · goldAbstract readReview
In one paragraph

Review in Toxins, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
28.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 144 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Influence of Ultrasound-Assisted and Supercritical COMolecules (Basel, Switzerland) · 2026
    Article
  14. Molecular docking-guided discovery ofPhysiology and molecular biology of plants : an international journal of functional plant biology · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Extracts of the Algerian FungusJournal of fungi (Basel, Switzerland) · 2025
    Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ana GuimarãesCentre of Biological Engineering, University of Minho, 4710-057 Braga, Portugal.ORCID 0000-0002-2219-2803
Armando VenâncioCentre of Biological Engineering, University of Minho, 4710-057 Braga, Portugal.ORCID 0000-0002-0723-6134
University of Minho · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungal contamination presents several problems: in humans, health issues arise from infections with opportunistic filamentous fungi and yeast, while in food, fungi cause spoilage and, in particular, in the case of mycotoxigenic fungi, can cause serious health issues. Several types of fatty acids and their derivatives, oxylipins, have been found to have inhibitory effect towards fungal growth and the production of mycotoxins. The use of fatty acids as antifungals could fulfil consumer's requests of more natural and environmentally friendly compounds, while being less likely to promote fungal resistance. In addition, due to their nature, fatty acids are easily used as food additives. In this work, we review the most relevant and recent studies on the antifungal ability of fatty acids. We focused on saturated fatty acids, unsaturated fatty acids, and oxylipins, their different impact on fungal inhibition, their proposed modes of action, and their ability to impair mycotoxin production. Applications of fatty acids as antifungals and their limitations are also addressed.

Indexed as

Antifungal AgentsMycotoxinsFatty AcidsFungiHumansOxylipinsAntifungal AgentsFatty AcidsMycotoxinsOxylipinsfungal contaminationhydroxy fatty acidmycotoxinsoxylipinssaturated fatty acidsunsaturated fatty acids

Identifiers

PMID35324685
PMCPMC8954725
OpenAlexW4214893804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.